Inventor · disambiguated record
Flavio Solca
Also filed as: SOLCA FLAVIO
37 granted patents·47 pending applications·1,464 citations·filing 2000–2021
98Inventor score
Files withBOEHRINGER INGELHEIM INT34BOEHRINGER INGELHEIM PHARMA27SOLCA FLAVIO8HIMMELSBACH FRANK3DENIS LOUIS2
Top patents by PatentIndex Score
84 records- 0198US6653305B2Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing themBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Nov 25, 2003·93 cites·8 claims
- 0298US6627634B2Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing themBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Sep 30, 2003·100 cites·9 claims
- 0397USRE43431EQuinazoline derivatives and pharmaceutical compositions containing themHIMMELSBACH FRANK·Filed 2009·Granted May 29, 2012·37 cites·12 claims
- 0497US7750152B2Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions and processes of making the sameBOEHRINGER INGELHEIM PHARMA·Filed 2007·Granted Jul 6, 2010·47 cites·12 claims
- 0597US7241889B26-formyl-tetrahydropteridines, process for their manufacture and use thereof as medicamentsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jul 10, 2007·70 cites·8 claims
- 0697US7119084B2Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing themBOEHRINGER INGELHEIM INT·Filed 2005·Granted Oct 10, 2006·51 cites·6 claims
- 0797US6861422B2Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Mar 1, 2005·115 cites·8 claims
- 0897US6656946B2Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Dec 2, 2003·79 cites·6 claims
- 0996US8003786B2Dihydropteridinone compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2010·Granted Aug 23, 2011·34 cites·1 claims
- 1096US7846936B2Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesisBOEHRINGER INGELHEIM INT·Filed 2008·Granted Dec 7, 2010·42 cites·5 claims
- 1196US7786299B2Methods for treating diseases or conditions using dihydropteridinone compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Aug 31, 2010·19 cites·14 claims
- 1296US7414053B2Dihydropteridione derivatives, process for their manufacture and their use as medicamentBOEHRINGER INGELHEIM INT·Filed 2005·Granted Aug 19, 2008·50 cites·9 claims
- 1396US7332491B2Dihydropteridione derivatives, process for their manufacture and their use as medicamentBOEHRINGER INGELHEIM INT·Filed 2005·Granted Feb 19, 2008·62 cites·7 claims
- 1496US7019012B2Quinazoline derivatives and pharmaceutical compositions containing themBOEHRINGER INGELHEIM INT·Filed 2001·Granted Mar 28, 2006·64 cites·6 claims
- 1596US6924285B2Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing themBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Aug 2, 2005·63 cites·9 claims
- 1695US7759347B22-benzylaminodihydropteridinones, process for their manufacture and use thereof as medicamentsBOEHRINGER INGELHEIM INT·Filed 2009·Granted Jul 20, 2010·32 cites·8 claims
- 1795US7220750B2Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing themBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted May 22, 2007·71 cites·9 claims
- 1895US6740651B2Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted May 25, 2004·90 cites·8 claims
- 1995US6403580B1Quinazolines, pharmaceutical compositions containing these compounds, their use and processes for preparing themBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Jun 11, 2002·70 cites·8 claims
- 2094US6972288B14-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Dec 6, 2005·81 cites·15 claims
- 2194US6617329B2Aminoquinazolines and their use as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Sep 9, 2003·65 cites·8 claims
- 2292US7910731B2Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing themBOEHRINGER INGELHEIM PHARMA·Filed 2008·Granted Mar 22, 2011·14 cites·17 claims
- 2392US7521457B2Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Apr 21, 2009·27 cites·11 claims
- 2492US7223749B2Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing themBOEHRINGER INGELHEIM INT·Filed 2004·Granted May 29, 2007·26 cites·7 claims
- 2589US8404697B2Quinazoline derivatives for the treatment of cancer diseasesSOLCA FLAVIO·Filed 2006·Granted Mar 26, 2013·14 cites·2 claims
- 2686US7569561B22,4-diaminopyrimidines useful for treating cell proliferation diseasesBOEHRINGER INGELHEIM INT·Filed 2007·Granted Aug 4, 2009·11 cites·8 claims
- 2781US8877764B2Method for treating cancer harboring EGFR mutationsSOLCA FLAVIO·Filed 2007·Granted Nov 4, 2014·5 cites·5 claims
- 2881US8828391B2Method for EGFR directed combination treatment of non-small cell lung cancerDENIS LOUIS·Filed 2012·Granted Sep 9, 2014·11 cites·16 claims
- 2981US8207179B2Substituted indolines as tyrosine kinase inhibitorsENGELHARDT HARALD·Filed 2008·Granted Jun 26, 2012·8 cites·4 claims
- 3080US9539258B2Quinazoline derivatives for the treatment of cancer diseasesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jan 10, 2017·2 cites·5 claims
- 3180US7863281B2Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereofBOEHRINGER INGELHEIM PHARMA·Filed 2007·Granted Jan 4, 2011·3 cites·8 claims
- 3279US9089571B2Quinazoline derivatives for the treatment of cancer diseasesSOLCA FLAVIO·Filed 2013·Granted Jul 28, 2015·3 cites·3 claims
- 3377US8586608B2Quinazoline derivatives and pharmaceutical compositions containing themBOEHRINGER INGELHEIM PHARMA·Filed 2009·Granted Nov 19, 2013·1 cites·3 claims
- 3477US8343982B2Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the sameBOEHRINGER INGELHEIM PHARMA·Filed 2010·Granted Jan 1, 2013·2 cites·34 claims
- 3572US11198726B2Anti-cancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 14, 2021·1 cites·6 claims
- 3671US8722694B2Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing themHIMMELSBACH FRANK·Filed 2012·Granted May 13, 2014·1 cites·9 claims
- 3768US2010069414A1Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing themBOEHRINGER INGELHEIM PHARMA·Filed 2009·Application pending·0 cites
- 3864US2009163465A1Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 3964US2009203683A1Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing themBOEHRINGER INGELHEIM PHARMA·Filed 2009·Application pending·0 cites
- 4064US2009149438A1Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 4162US2014057898A1Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesisSTEFANIC MARTIN FRIEDRICH·Filed 2013·Application pending·0 cites
- 4261US2007185091A1Bicyclic Heterocycles, Pharmaceutical Compositions Containing These Compounds, Their Use and Processes for Preparing ThemBOEHRINGER INGELHEIM PHARMA·Filed 2007·Application pending·0 cites
- 4361US2006270672A1Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing themHIMMELSBACH FRANK·Filed 2006·Application pending·0 cites
- 4461US2022340651A1Anti cancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 4560US2007185081A1Bicyclic heterocylces, pharmaceutical compositions containing these compounds, their use and processes for preparing themBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 4660US2018360834A1Quinazoline derivatives for the treatment of cancer diseasesBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 4760US2005014760A1Methods of treating diseases or conditions using dihydropteridinone compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 4859US2006100223A1Quinazoline derivatives and pharmaceutical compositions containing themBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 4959US2005014761A1Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 5058US2013289014A1Combination therapy in treatment of oncological and fibrotic diseasesSOLCA FLAVIO·Filed 2013·Application pending·0 cites
Showing the top 50 of 84 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →